The University of Kansas Cancer Center, North Clinic

Kansas City, Missouri 64154

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer Metastatic, HER2-positive Breast Cancer, NSCLC Stage IIIB, NSCLC Stage IV, Non Small Cell Lung Cancer Stage, Triple-negative Breast Cancer

Studies at this site

• Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer — Recruiting now
• Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer — Status unconfirmed
• Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer — Stopped early
• Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy — Status unconfirmed
• Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer — Status unconfirmed